Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004381 · ClinicalTrials.gov registry record · Phase 2
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
A Phase 2 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00004381: Completed Phase 2 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT00004381 is a Phase 2 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004381, a Phase 2 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
OBJECTIVES: I. Compare the efficacy of preventive vs. therapeutic tin mesoporphyrin in direct Coombs' test-positive ABO hemolytic disease of the newborn and glucose-6-phosphate dehydrogenase deficiency in infants living in Greece. II. Assess the safety of tin mesoporphyrin in high-risk newborns.
Interventions
- DRUG tin mesoporphyrin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-12 |
| Phase | Phase 2 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What the finished NCT00004381 record still lists
NCT00004381 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which tin mesoporphyrin is the first listed.
NCT00004381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004381 about?
NCT00004381 is a clinical study titled "Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia". OBJECTIVES: I. Compare the efficacy of preventive vs. therapeutic tin mesoporphyrin in direct Coombs' test-positive ABO hemolytic disease of the newborn and glucose-6-phosphate dehydrogenase deficiency in infants living in Greece. II. Assess the safety of tin mesoporphyrin in high-risk newborns.
What is the current status of trial NCT00004381?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-12.
What interventions are being tested in trial NCT00004381?
The interventions under investigation include: tin mesoporphyrin (DRUG).
Who is sponsoring clinical trial NCT00004381?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia